OBJECTIVE: To test the hypothesis that 12-lead ECG QRS scoring quantifies myocardial scar and correlates with disease severity in Chagas' heart disease. DESIGN: Patients underwent 12-lead ECG for QRS scoring and cardiac magnetic resonance with late gadolinium enhancement (CMR-LGE) to assess myocardial scar. SETTING: University of São Paulo Medical School, São Paulo, Brazil. PATIENTS: 44 Seropositive patients with Chagas' disease without a history of myocardial infarction and at low risk for coronary artery disease. MAIN OUTCOME MEASURES: Correlation between QRS score, CMR-LGE scar size and left ventricular ejection fraction. Relation between QRS score, heart failure (HF) class and history of ventricular tachycardia (VT). RESULTS: QRS score correlated directly with CMR-LGE scar size (R=0.69, p<0.0001) and inversely with left ventricular ejection fraction (R=-0.54, p=0.0002), which remained significant in the subgroup with conduction defects. Patients with class II or III HF had significantly higher QRS scores than those with class I HF (5.1±3.4 vs 2.1±3.1 QRS points (p=0.002)) and patients with a history of VT had significantly higher QRS scores than those without a history of VT (5.3±3.2% vs 2.6±3.4 QRS points (p=0.02)). A QRS score ≥2 points had particularly good sensitivity and specificity (95% and 83%, respectively) for prediction of large CMR-LGE, and a QRS score ≥7 points had particularly high specificity (92% and 89%, respectively) for predicting significant left ventricular dysfunction and history of VT. CONCLUSIONS: The wide availability of 12-lead ECG makes it an attractive screening tool and may enhance clinical risk stratification of patients at risk for more severe, symptomatic Chagas' heart disease.
OBJECTIVE: To test the hypothesis that 12-lead ECG QRS scoring quantifies myocardial scar and correlates with disease severity in Chagas' heart disease. DESIGN:Patients underwent 12-lead ECG for QRS scoring and cardiac magnetic resonance with late gadolinium enhancement (CMR-LGE) to assess myocardial scar. SETTING: University of São Paulo Medical School, São Paulo, Brazil. PATIENTS: 44 Seropositive patients with Chagas' disease without a history of myocardial infarction and at low risk for coronary artery disease. MAIN OUTCOME MEASURES: Correlation between QRS score, CMR-LGE scar size and left ventricular ejection fraction. Relation between QRS score, heart failure (HF) class and history of ventricular tachycardia (VT). RESULTS: QRS score correlated directly with CMR-LGE scar size (R=0.69, p<0.0001) and inversely with left ventricular ejection fraction (R=-0.54, p=0.0002), which remained significant in the subgroup with conduction defects. Patients with class II or III HF had significantly higher QRS scores than those with class I HF (5.1±3.4 vs 2.1±3.1 QRS points (p=0.002)) and patients with a history of VT had significantly higher QRS scores than those without a history of VT (5.3±3.2% vs 2.6±3.4 QRS points (p=0.02)). A QRS score ≥2 points had particularly good sensitivity and specificity (95% and 83%, respectively) for prediction of large CMR-LGE, and a QRS score ≥7 points had particularly high specificity (92% and 89%, respectively) for predicting significant left ventricular dysfunction and history of VT. CONCLUSIONS: The wide availability of 12-lead ECG makes it an attractive screening tool and may enhance clinical risk stratification of patients at risk for more severe, symptomatic Chagas' heart disease.
Authors: Fabiana S Machado; Linda A Jelicks; Louis V Kirchhoff; Jamshid Shirani; Fnu Nagajyothi; Shankar Mukherjee; Randin Nelson; Christina M Coyle; David C Spray; Antonio C Campos de Carvalho; Fangxia Guan; Cibele M Prado; Michael P Lisanti; Louis M Weiss; Susan P Montgomery; Herbert B Tanowitz Journal: Cardiol Rev Date: 2012 Mar-Apr Impact factor: 2.644
Authors: David G Strauss; Nathan Mewton; Richard L Verrier; Bruce D Nearing; Francis E Marchlinski; Tony Killian; John Moxley; Larisa G Tereshchenko; Katherine C Wu; Raimond Winslow; Christopher Cox; Peter M Spooner; João A C Lima Journal: Circ Arrhythm Electrophysiol Date: 2013-10-12
Authors: Eva H Clark; Morgan A Marks; Robert H Gilman; Antonio B Fernandez; Thomas C Crawford; Aaron M Samuels; Alicia I Hidron; Gerson Galdos-Cardenas; Gilberto Silvio Menacho-Mendez; Ricardo W Bozo-Gutierrez; Diana L Martin; Caryn Bern Journal: Am J Trop Med Hyg Date: 2014-11-10 Impact factor: 2.345
Authors: Nathan Mewton; David G Strauss; Patricia Rizzi; Richard L Verrier; Chia Ying Liu; Larisa G Tereshchenko; Bruce Nearing; Gustavo J Volpe; Francis E Marchlinski; John Moxley; Tony Killian; Katherine C Wu; Peter Spooner; João A C Lima Journal: Ann Noninvasive Electrocardiol Date: 2016-01 Impact factor: 1.468
Authors: Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro Journal: Expert Rev Cardiovasc Ther Date: 2015-10-23